IN2012DN00707A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00707A IN2012DN00707A IN707DEN2012A IN2012DN00707A IN 2012DN00707 A IN2012DN00707 A IN 2012DN00707A IN 707DEN2012 A IN707DEN2012 A IN 707DEN2012A IN 2012DN00707 A IN2012DN00707 A IN 2012DN00707A
- Authority
- IN
- India
- Prior art keywords
- biomarkers
- samples
- endometrial cancer
- compared
- differentially expressed
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09166398 | 2009-07-24 | ||
| PCT/EP2010/004550 WO2011009637A2 (en) | 2009-07-24 | 2010-07-23 | Markers for endometrial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00707A true IN2012DN00707A (enExample) | 2015-06-19 |
Family
ID=42751506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN707DEN2012 IN2012DN00707A (enExample) | 2009-07-24 | 2010-07-23 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9046522B2 (enExample) |
| EP (2) | EP2848700B1 (enExample) |
| JP (1) | JP5934093B2 (enExample) |
| KR (1) | KR101828290B1 (enExample) |
| CN (2) | CN105132529A (enExample) |
| AU (1) | AU2010275699B2 (enExample) |
| BR (1) | BR112012001469B1 (enExample) |
| CA (1) | CA2767914C (enExample) |
| DK (1) | DK2456889T3 (enExample) |
| ES (2) | ES2654340T3 (enExample) |
| HR (1) | HRP20141062T1 (enExample) |
| IN (1) | IN2012DN00707A (enExample) |
| MX (1) | MX2012000921A (enExample) |
| PL (1) | PL2456889T3 (enExample) |
| PT (1) | PT2456889E (enExample) |
| RU (1) | RU2596394C2 (enExample) |
| WO (1) | WO2011009637A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN00707A (enExample) * | 2009-07-24 | 2015-06-19 | Geadic Biotec Aie | |
| WO2013044187A2 (en) * | 2011-09-22 | 2013-03-28 | Memorial Sloan-Kettering Cancer Center | Detecting ovarian cancer |
| EP2787350A1 (en) * | 2013-04-05 | 2014-10-08 | Atlas Antibodies AB | ASRGL1 in endometrial cancer |
| KR102113310B1 (ko) * | 2013-09-03 | 2020-05-20 | 아주대학교 산학협력단 | 암 세포 분리용 조성물, 키트 및 이를 이용한 분리 방법 |
| CA2956723C (en) | 2014-08-12 | 2023-04-11 | Nextgen Jane, Inc. | System and method for monitoring health based on collected bodily fluid |
| ES2897782T3 (es) * | 2014-09-17 | 2022-03-02 | Merck Patent Gmbh | Método de tratamiento de las enfermedades de la metástasis ósea, medicamentos para el tratamiento y método para predecir el resultado clínico del tratamiento de las enfermedades causadas por metástasis ósea |
| CN107102141A (zh) * | 2016-02-23 | 2017-08-29 | 中国科学院生物物理研究所 | 分子标记物cd71及在子宫内膜癌诊断、分期及预后中的应用 |
| EP3442706B1 (en) | 2016-04-13 | 2025-07-23 | NextGen Jane, Inc. | Sample collection and preservation methods |
| JP7240712B2 (ja) * | 2016-05-04 | 2023-03-16 | フンダシオ オスピタル ウニベルシタリ バル デブロン-インスティテュート デ レセルカ | 子宮内膜がんのマーカーとしてのperm |
| GB201702392D0 (en) * | 2017-02-14 | 2017-03-29 | Univ Edinburgh | Methods for cancer diagnosis using a gene expression signature |
| CN108732351A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Eps8l2作为指示肝内结节及早期预警肝癌的生物标志物 |
| CN108732349A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Lta4h作为指示肝内结节及早期预警肝癌的生物标志物 |
| CN108732350A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Pla2g6作为指示肝内结节及早期预警肝癌的生物标志物 |
| CN109085359A (zh) * | 2017-06-13 | 2018-12-25 | 中国医学科学院肿瘤医院 | 血清蛋白标志物组合在结直肠癌筛查和诊治中的应用 |
| PT3655778T (pt) * | 2017-07-21 | 2023-08-18 | Fundacio Hospital Univ Vall Dhebron Institut De Recerca | Agrin como marcador de cancro do endométrio |
| JP2021526812A (ja) * | 2018-06-13 | 2021-10-11 | 23イキガイ ピーティーイー リミテッド | 多能性幹細胞バイオマーカーを分析するための方法およびその実施 |
| CN109097462B (zh) * | 2018-09-10 | 2022-01-11 | 青岛市海慈医疗集团 | Ap1m2基因作为诊断青光眼的分子标志物的应用 |
| WO2020130190A1 (ko) * | 2018-12-20 | 2020-06-25 | 경상대학교병원 | 신장암의 발병 위험성 예측 또는 진단을 위한 정보제공방법 |
| EP3914163A4 (en) * | 2019-01-23 | 2022-04-13 | Gina-Life Diagnostics Ltd. | CANCER DIAGNOSTIC AND MONITORING APPARATUS, SYSTEMS AND METHODS |
| CN109797217A (zh) * | 2019-03-27 | 2019-05-24 | 河北医科大学第二医院 | 帕金森生物标志物及其在制备检测产品中的应用 |
| CN109811058B (zh) * | 2019-03-31 | 2021-11-12 | 青岛泱深生物医药有限公司 | 与宫颈疾病发生发展相关的生物标志物及其应用 |
| US20240218454A1 (en) * | 2021-04-22 | 2024-07-04 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Diagnostic to support clinical trial matching and exploratory biomarker analyses in cancer patients |
| CN114317750B (zh) * | 2021-12-29 | 2024-05-14 | 上海市第十人民医院 | 一种卵巢癌生物标志物及其在制备用于卵巢癌腹水转移疾病的药物或试剂盒中的应用 |
| KR102584898B1 (ko) * | 2022-10-24 | 2023-10-04 | 연세대학교 산학협력단 | 자궁내막암 진단 방법 및 이를 이용한 키트 |
| WO2024192014A1 (en) * | 2023-03-12 | 2024-09-19 | Novelna Inc. | Endometrial cancer detection proteins and methods of use thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| AUPO573697A0 (en) * | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
| US7014996B1 (en) * | 1998-10-02 | 2006-03-21 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| AUPQ219799A0 (en) | 1999-08-13 | 1999-09-02 | R. Lurie Pty Ltd | Apparatus for obtaining potological samples |
| US6884578B2 (en) | 2000-03-31 | 2005-04-26 | Affymetrix, Inc. | Genes differentially expressed in secretory versus proliferative endometrium |
| RU2232397C2 (ru) * | 2002-04-03 | 2004-07-10 | НИИ онкологии им. проф. Н.Н. Петрова | Способ ранней диагностики патологических состояний эндометрия |
| US20040063120A1 (en) * | 2002-07-10 | 2004-04-01 | The Regents Of The University Of Michigan | Expression profile of lung cancer |
| WO2004105573A2 (en) * | 2003-05-21 | 2004-12-09 | The Wistar Institute Of Anatomy And Biology | Method of diagnosis of cancer based on gene expression profiles in cells |
| WO2005034978A2 (en) | 2003-10-02 | 2005-04-21 | Xantos Biomedicine Ag | MEDICAL USE OF IKKϵ OR OF INHIBITORS THEREOF |
| JP5629894B2 (ja) | 2004-12-07 | 2014-11-26 | 国立大学法人大阪大学 | 甲状腺乳頭癌を診断するための新規のマーカー |
| EP2295601A1 (en) | 2005-02-10 | 2011-03-16 | Oncotherapy Science, Inc. | Method of diagnosing bladder cancer |
| EP2266561A3 (en) * | 2005-09-07 | 2011-05-18 | Merck Serono S.A. | IKK Inhibitors for the Treatment of Endometriosis |
| US20070134687A1 (en) * | 2005-09-12 | 2007-06-14 | Aurelium Biopharma Inc. | Focused microarray and methods of diagnosing cancer |
| CN101384903A (zh) * | 2006-02-09 | 2009-03-11 | 南佛罗里达大学 | 利用bcl-2水平的增高检测癌肿 |
| US20070287158A1 (en) * | 2006-06-09 | 2007-12-13 | George Gorodeski | Cell collection and disease screening |
| EP1978106A1 (en) | 2007-04-07 | 2008-10-08 | Universitätsklinikum Hamburg-Eppendorf | Detection of ESR1 amplification in endometrium cancer and ovary cancer |
| WO2008137591A2 (en) | 2007-05-02 | 2008-11-13 | Biocept, Inc. | Non-invasive detection of endometrial cancer |
| JP5419195B2 (ja) | 2007-08-03 | 2014-02-19 | 国立大学法人愛媛大学 | 頭頸部癌の腫瘍マーカー |
| US20110136123A1 (en) * | 2007-08-15 | 2011-06-09 | Universite De Sherbrooke | Alternative splicing gene variants in cancer |
| US8053198B2 (en) * | 2007-09-14 | 2011-11-08 | Meso Scale Technologies, Llc | Diagnostic methods |
| US20110028344A1 (en) | 2008-04-11 | 2011-02-03 | Expression Pathology, Inc. | Biomarkers for endometrial disease |
| IN2012DN00707A (enExample) * | 2009-07-24 | 2015-06-19 | Geadic Biotec Aie |
-
2010
- 2010-07-23 IN IN707DEN2012 patent/IN2012DN00707A/en unknown
- 2010-07-23 WO PCT/EP2010/004550 patent/WO2011009637A2/en not_active Ceased
- 2010-07-23 EP EP14183077.8A patent/EP2848700B1/en not_active Not-in-force
- 2010-07-23 EP EP10736990.2A patent/EP2456889B1/en active Active
- 2010-07-23 ES ES14183077.8T patent/ES2654340T3/es active Active
- 2010-07-23 MX MX2012000921A patent/MX2012000921A/es active IP Right Grant
- 2010-07-23 RU RU2012106432/10A patent/RU2596394C2/ru active
- 2010-07-23 KR KR1020127004840A patent/KR101828290B1/ko not_active Expired - Fee Related
- 2010-07-23 HR HRP20141062AT patent/HRP20141062T1/hr unknown
- 2010-07-23 PL PL10736990T patent/PL2456889T3/pl unknown
- 2010-07-23 CN CN201510425228.XA patent/CN105132529A/zh active Pending
- 2010-07-23 ES ES10736990.2T patent/ES2523683T3/es active Active
- 2010-07-23 DK DK10736990.2T patent/DK2456889T3/en active
- 2010-07-23 AU AU2010275699A patent/AU2010275699B2/en not_active Ceased
- 2010-07-23 US US13/386,536 patent/US9046522B2/en active Active
- 2010-07-23 CA CA2767914A patent/CA2767914C/en active Active
- 2010-07-23 PT PT107369902T patent/PT2456889E/pt unknown
- 2010-07-23 BR BR112012001469-2A patent/BR112012001469B1/pt not_active IP Right Cessation
- 2010-07-23 JP JP2012520964A patent/JP5934093B2/ja not_active Expired - Fee Related
- 2010-07-23 CN CN201080042678.6A patent/CN102549169B/zh not_active Expired - Fee Related
-
2015
- 2015-06-01 US US14/727,549 patent/US20150337392A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2654340T3 (es) | 2018-02-13 |
| RU2012106432A (ru) | 2013-08-27 |
| CN102549169A (zh) | 2012-07-04 |
| RU2596394C2 (ru) | 2016-09-10 |
| US20120122726A1 (en) | 2012-05-17 |
| EP2456889B1 (en) | 2014-09-03 |
| EP2456889A2 (en) | 2012-05-30 |
| BR112012001469A2 (pt) | 2020-08-11 |
| US9046522B2 (en) | 2015-06-02 |
| HRP20141062T1 (hr) | 2015-01-02 |
| US20150337392A1 (en) | 2015-11-26 |
| CN105132529A (zh) | 2015-12-09 |
| EP2848700A1 (en) | 2015-03-18 |
| CN102549169B (zh) | 2016-02-24 |
| AU2010275699A1 (en) | 2012-02-02 |
| MX2012000921A (es) | 2012-06-12 |
| AU2010275699B2 (en) | 2016-06-16 |
| CA2767914C (en) | 2020-02-25 |
| JP5934093B2 (ja) | 2016-06-15 |
| WO2011009637A3 (en) | 2011-04-14 |
| EP2848700B1 (en) | 2017-10-04 |
| JP2013500001A (ja) | 2013-01-07 |
| ES2523683T3 (es) | 2014-11-28 |
| CA2767914A1 (en) | 2011-01-27 |
| BR112012001469B1 (pt) | 2021-08-10 |
| KR20120047334A (ko) | 2012-05-11 |
| PL2456889T3 (pl) | 2015-02-27 |
| PT2456889E (pt) | 2014-11-21 |
| KR101828290B1 (ko) | 2018-02-12 |
| WO2011009637A2 (en) | 2011-01-27 |
| DK2456889T3 (en) | 2014-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00707A (enExample) | ||
| WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
| WO2009019368A3 (fr) | Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal | |
| WO2018091740A3 (en) | Novel anti_cd137 antibodies and uses thereof | |
| MY196078A (en) | Quinoline Derivatives As Tam Rtk Inhibitors | |
| MX368513B (es) | Métodos in vitro para el pronóstico, diagnóstico y diseño de una terapia de metástasis de cáncer de pulmón. | |
| IN2012DN01403A (enExample) | ||
| WO2008008430A3 (en) | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases | |
| WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
| WO2008117314A3 (en) | Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| EA201400117A1 (ru) | Способы и нуклеиновые кислоты для определения прогноза у больных раком | |
| HK1213946A1 (zh) | 用於使用c-maf对前列腺癌转移进行诊断、预後和治疗的方法 | |
| MY179845A (en) | Specific biomarker set for non-invasive diagnosis of liver cancer | |
| WO2012078053A8 (en) | Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder | |
| WO2013172779A3 (en) | Method for indicating the presence or non-presence of prostate cancer | |
| WO2006028655A3 (en) | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
| EA201291346A1 (ru) | Полиморфы osi-906 | |
| MX339340B (es) | Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico. | |
| WO2011143575A3 (en) | smFRET WITH MEMBRANE PROTEINS | |
| Ogorodnik et al. | Analysis of the 3′-variable region of the cagA gene from Helicobacter pylori strains infecting patients at New York City hospitals | |
| IN2012DN05143A (enExample) | ||
| WO2010051261A3 (en) | A genetic marker for detection of human papillomavirus | |
| WO2010082004A9 (fr) | Procedes pour determiner la susceptibilite a contracter une infection nosocomiale chez un patient et pour etablir un pronostic d'evolution d'un syndrome septique | |
| EA201290107A1 (ru) | Способ определения пациента как восприимчивого или не восприимчивого к иммунотерапии | |
| MY148542A (en) | A method for the assessment of cancer in a biological sample obtained from a subject |